|
|
 |
| MACS® GMP Recombinant Human Interleukin 1β |
|
| Description |
Interleukin-1 beta (IL-1β) is a pro-inflammatory cytokine that is secreted mainly by monocytes and macrophages. IL-1β secretion has also been reported for a variety of other cells, including B cells, NK cells, dendritic cells, astrocytes, and microglial cells. It mediates inflammatory responses in B cells, T cells, and NK cells by inducing the production of cytokines, such as IL-2, IL-3, IL-6, as well as interferons.
MACS GMP Recombinant Human Interleukin 1β is lyophilized without carrier protein or preservatives. A lot-specific certificate confirms identity, molecular mass, specific activity, sterility, purity, endotoxin content, and host-cell DNA content. |
| Applications |
MACS GMP Recombinant Human Interleukin 1β can be used for a variety of applications, including the ex vivo generation of human dendritic cells from enriched CD14+ monocyte populations.1-3 MACS GMP Recombinant Human Interleukin 1β is not intended for human in vivo application.
|
| Quality Statement |
MACS GMP Recombinant Human Interleukin 1β may be used for research or ex vivo cell culture processing. MACS GMP Recombinant Human Interleukin 1β is manufactured and tested under a certified ISO 9001 quality system and in compliance with relevant GMP guidelines. It is designed following the recommendations of USP <1043> on ancillary materials. No animal- or human-derived components are used for manufacturing. |
| | |
|
 |
| My favorites |
| Your current favorite list is empty. |
|
| Products |
| MACS GMP Recombinant Human IL-1β |
| For research or ex vivo cell culture processing |
| Availability: Worldwide (1) |
Components - 25 μg Download datasheet 170-076-102
|
| (1) For availability in your country please contact your local representative. |
|
| References |
| 1. Bender et al. (1996) J. Immunol. Methods 196: 121–135. |
| 2. Romani et al. (1996) J. Immunol. Methods 196: 137–151. |
| 3. Jonuleit et al. (1997) Eur. J. Immunol. 27: 3135–3142. |
|
|
|
© 1999 - 2010 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|